Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology?
This review provides perspectives on the utility of magnetic resonance imaging (MRI) as a neuroimaging approach in the development of novel treatments for Alzheimer's disease. These considerations were generated in a roundtable at a recent Wellcome Trust meeting that included experts from acade...
主要な著者: | Merlo Pich, E, Jeromin, A, Frisoni, G, Hill, D, Lockhart, A, Schmidt, M, Turner, M, Mondello, S, Potter, W |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
BioMed Central
2014
|
類似資料
-
Advances in Cardiovascular Biomarker Discovery
著者:: Crystal M. Ghantous, 等
出版事項: (2020-11-01) -
Multinuclear MRI in Drug Discovery
著者:: Dorota Bartusik-Aebisher, 等
出版事項: (2022-10-01) -
Open drug discovery in Alzheimer's disease
著者:: Alison D. Axtman, 等
出版事項: (2023-04-01) -
Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia
著者:: Winchester, LM, 等
出版事項: (2023) -
The role of fMRI in drug discovery.
著者:: Wise, R, 等
出版事項: (2006)